# Graftech International Ltd: Form 10-Q for the period ended Jun 30, 2020

- Company: [Graftech International Ltd](/companies/eaf.md) (CIK 931148)
- Form: 10-Q
- Filed: 2020-08-06
- Accepted by EDGAR: Aug 6, 2020, 17:19 ET
- Period: 2020-06-30
- Accession: 0000931148-20-000107
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/931148/000093114820000107/gti-20200630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/931148/000093114820000107/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-04-01 to 2020-06-30 | $280.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2020-01-01 to 2020-06-30 | $599.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2020-04-01 to 2020-06-30 | $130.6m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2020-01-01 to 2020-06-30 | $269.5m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2020-04-01 to 2020-06-30 | $150.1m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2020-01-01 to 2020-06-30 | $329.8m | us-gaap:GrossProfit |
| Research and development | 3 months, 2020-04-01 to 2020-06-30 | $710.0k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2020-01-01 to 2020-06-30 | $1.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2020-04-01 to 2020-06-30 | $16.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2020-01-01 to 2020-06-30 | $30.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-04-01 to 2020-06-30 | $133.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2020-01-01 to 2020-06-30 | $297.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2020-04-01 to 2020-06-30 | $20.9m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2020-01-01 to 2020-06-30 | $46.6m | us-gaap:InterestExpense |
| Income tax | 3 months, 2020-04-01 to 2020-06-30 | $19.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2020-01-01 to 2020-06-30 | $43.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-04-01 to 2020-06-30 | $92.8m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2020-01-01 to 2020-06-30 | $215.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-04-01 to 2020-06-30 | $0.35 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2020-01-01 to 2020-06-30 | $0.80 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-04-01 to 2020-06-30 | $0.35 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2020-01-01 to 2020-06-30 | $0.80 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-04-01 to 2020-06-30 | 267,260,395 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2020-01-01 to 2020-06-30 | 268,243,997 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2020-01-01 to 2020-06-30 | $287.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2020-01-01 to 2020-06-30 | $24.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2020-04-01 to 2020-06-30 | $679.0k | us-gaap:PaymentsOfDividends |
| Dividends paid | 6 months, 2020-01-01 to 2020-06-30 | $6.6m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months, 2020-01-01 to 2020-06-30 | $30.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-06-30 | $187.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-06-30 | $713.0m | us-gaap:AssetsCurrent |
| Total assets | at 2020-06-30 | $1.53bn | us-gaap:Assets |
| Current liabilities | at 2020-06-30 | $230.2m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2020-06-30 | $1.70bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2020-06-30 | $8.1m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2020-06-30 | $8.1m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2020-06-30 | −$574.7m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 41,569 characters.

### The Company

GrafTech is a leading manufacturer of graphite electrodes, the critical consumable for the electric arc furnace industry. We are the only graphite electrode producer that is substantially vertically integrated into petroleum needle coke, a key raw material for graphite electrodes. Vertical integration has allowed us to adopt a commercial strategy with long-term, fixed price, fixed volume, take-or-pay contracts providing earnings stability and visibility. These contracts define volumes and prices, along with price-escalation mechanisms for inflation, and include significant termination payments (typically, 50% to 70% of remaining contracted revenue) and, in certain cases, parent guarantees and collateral arrangements to manage our customer credit risk.

### COVID-19

GrafTech has been successful in managing through the COVID-19 pandemic. We have quickly adapted to changing situations throughout all of the regions of the world in which we operate and conduct business. Our executive-led COVID-19 response team continues to meet three times per week to monitor the situation and adapt as needed. We continue to limit travel and have employees working from home where possible. Our facilities perform temperature measurement upon entry and our team members continue to use personal protective equipment, such as masks and gloves. Daily disinfecting activities are performed and strict adherence to social distancing guidelines is required. All of these activities are guided by our "COVID-Safe-Work Playbook" and "Return to Work Protocols" and are closely monitored with daily "check sheets". The result of this hard work is that we have managed to keep 99% of our employees healthy to date.

### Commercial Update

GrafTech services customers at over 300 locations across the globe all of which have been impacted by COVID-19. The recovery for some customers has begun, however, each region is impacted and recovering at significantly different rates.

The commercial team worked diligently to achieve solid results in the second quarter of 2020. We delivered a total 31,000 metric tons ("MT") in the second quarter, of which 26,000 MT represented deliveries under our long-term agreements ("LTAs") and 5,000 MT were the result of spot sales. Our total deliveries under our LTAs were 55,000 MT for the first half of 2020 and we continue to expect deliveries under the LTAs of 100,000-115,000 MT for the full year.

As anticipated, the spot price of graphite electrodes continued to trend lower during the second quarter. Our average price for non-LTA business in the second quarter was approximately $5,500 per MT and we expect further market spot price erosion in the third quarter. The needle coke market continued to soften as well.

The current market continues to challenge our customers including those with LTAs. Over the course of the COVID-19 pandemic, we have received force majeure claims from approximately 35 customers. Several customers are struggling to take their committed volumes causing some delays and non-performance including a few arbitrations associated with, among other things, efforts to modify the existing contracts.

We are working hard with our valued customers to develop mutually beneficial solutions to address the current challenging environment, but we will take every measure to ensure that customers fulfill their legal obligations and commitments under these contracts. These negotiations are ongoing and have successfully resulted in modifications with some of our strategic customers to provide near-term relief while extending the term of their contracts.

### Operational Update

We have been successful at keeping our plants operational through the COVID-19 pandemic. We have aligned our operations to our expected sales and have maintained a 98% on-time delivery rate through these difficult times. Our Seadrift plant recently completed its scheduled maintenance outage on time and on budget.

We have eliminated discretionary spending throughout the organization and adjusted our workforce to match current production levels. We met our goal of reducing fixed production costs by 15% in the second quarter of 2020 which assisted in achieving a 12% reduction year-to-date when compared to 2019 levels. We continue to manage our capital expenditures in line with our reduced target and expect approximately $35 million for the full year.

### Capital Structure and Capital Allocation

During the second quarter of 2020 we reduced our debt by approximately $103 million. We will continue to prioritize balance sheet flexibility and expect to use the majority of our incremental free cash flow in 2020 to reduce debt, but will continue to examine opportunities to repurchase stock.

### Outlook

The second half of 2020 will continue to be challenging as we and our customers face macro-economic headwinds. We foresee a measured recovery in the industry when the pandemic eases as customers work through graphite electrode inventory levels that were elevated prior to the onset of the pandemic. We expect overall demand and pricing to remain low for the remainder of 2020.

We have full confidence in the strengths of the Electric Arc Furnace and graphite electrode businesses. The environmental and economic attributes of these industries are key advantages and position them for continued growth over the longer term.

We believe GrafTech is well positioned to navigate the challenges of the current environment and the opportunities in the future recovery given our leadership position in the industry, our strong cash flows, and our advantaged cost position.

### Key metrics used by management to measure performance

In addition to measures of financial performance presented in our Consolidated Financial Statements in accordance with U.S. generally accepted accounting principles ("GAAP"), we use certain other financial measures and operating metrics to analyze the performance of our company. The “non-GAAP” financial measures consist of EBITDA and adjusted EBITDA, which help us evaluate growth trends, establish budgets, assess operational efficiencies and evaluate our overall financial performance. The key operating metrics consist of sales volume, production volume, production capacity and capacity utilization.

### Key financial measures

*(in thousands)*

|  | For the Three Months Ended June 30, 2020 | 2019 | For the Six Months Ended June 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $280,718 | $480,390 | $599,364 | $955,384 |
| Net income | 92,776 | 196,368 | 215,044 | 393,804 |
| EBITDA (1) | 147,645 | 281,818 | 332,674 | 560,543 |
| Adjusted EBITDA (1) | 151,125 | 284,404 | 330,303 | 568,219 |

(1) Non-GAAP financial measures; see below for information and a reconciliation of EBITDA and adjusted EBITDA to net income, the most directly comparable financial measure calculated and presented in accordance with GAAP.

### Key operating metrics

*(in thousands, except price data)*

|  | For the Three Months Ended June 30, 2020 | 2019 | For the Six Months Ended June 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| Sales volume (MT)(1) | 31 | 45 | 65 | 90 |
| Production volume (MT)(2) | 33 | 48 | 66 | 95 |
| Production capacity excluding St. Marys (MT)(3)(4) | 51 | 51 | 102 | 102 |
| Capacity utilization excluding St. Marys (3)(5) | 65% | 94% | 65% | 93% |
| Total production capacity (MT)(4)(6) | 58 | 58 | 116 | 116 |
| Total capacity utilization(5)(6) | 57% | 83% | 57% | 82% |

(1) Sales volume reflects only graphite electrodes manufactured by GrafTech.

(2) Production volume reflects graphite electrodes we produced during the period.

(3) In the first quarter of 2018, our St. Marys facility began graphitizing a limited amount of electrodes sourced from our Monterrey, Mexico facility.

(4) Production capacity reflects expected maximum production volume during the period under normal operating conditions, standard product mix and expected maintenance outage. Actual production may vary.

(5) Capacity utilization reflects production volume as a percentage of production capacity.

(6) Includes graphite electrode facilities in Calais, France; Monterrey, Mexico; Pamplona, Spain and St. Marys, Pennsylvania.

### Non-GAAP financial measures

In addition to providing results that are determined in accordance with GAAP, we have provided certain financial measures that are not in accordance with GAAP. EBITDA and adjusted EBITDA are non-GAAP financial measures. We define EBITDA, a non-GAAP financial measure, as net income or loss plus interest expense, minus interest income, plus income taxes, and depreciation and amortization. We define adjusted EBITDA as EBITDA plus any pension and other post-employment benefit ("OPEB") plan expenses, initial and follow-on public offering and related expenses, non-cash gains or losses from foreign currency remeasurement of non-operating assets and liabilities in our foreign subsidiaries where the functional currency is the U.S. dollar, related party Tax Receivable Agreement expense, stock-based compensation and non-cash fixed asset write-offs. Adjusted EBITDA is the primary metric used by our management and our board of directors to establish budgets and operational goals for managing our business and evaluating our performance.

We monitor adjusted EBITDA as a supplement to our GAAP measures, and believe it is useful to present to investors, because we believe that it facilitates evaluation of our period-to-period operating performance by eliminating items that are not operational in nature, allowing comparison of our recurring core business operating results over multiple periods unaffected by differences in capital structure, capital investment cycles and fixed asset base. In addition, we believe adjusted EBITDA and similar measures are widely used by investors, securities analysts, ratings agencies, and other parties in evaluating companies in our industry as a measure of financial performance and debt-service capabilities.

Our use of adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:

- adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
- adjusted EBITDA does not reflect our cash expenditures for capital equipment or other contractual commitments, including any capital expenditure requirements to augment or replace our capital assets;
- adjusted EBITDA does not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our indebtedness;
- adjusted EBITDA does not reflect tax payments that may represent a reduction in cash available to us;
- adjusted EBITDA does not reflect expenses relating to our pension and OPEB plans;
- adjusted EBITDA does not reflect the non-cash gains or losses from foreign currency remeasurement of non-operating assets and liabilities in our foreign subsidiaries where the functional currency is the U.S. dollar;
- adjusted EBITDA does not reflect initial and follow-on public offering and related expenses;
- adjusted EBITDA does not reflect related party Tax Receivable Agreement expense;
- adjusted EBITDA does not reflect stock-based compensation or the non-cash write-off of fixed assets; and
- other companies, including companies in our industry, may calculate EBITDA and adjusted EBITDA differently, which reduces its usefulness as a comparative measure.

In evaluating EBITDA and adjusted EBITDA, you should be aware that in the future, we will incur expenses similar to the adjustments in this presentation. Our presentations of EBITDA and adjusted EBITDA should not be construed as suggesting that our future results will be unaffected by these expenses or any unusual or non-recurring items. When evaluating our performance, you should consider EBITDA and adjusted EBITDA alongside other financial performance measures, including our net income (loss) and other GAAP measures.

The following table reconciles our non-GAAP key financial measures to the most directly comparable GAAP measures:

*(in thousands)*

|  | For the Three Months Ended June 30, 2020 | 2019 | For the Six Months Ended June 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| **Net income** | $92,776 | $196,368 | $215,044 | $393,804 |
| Add: |  |  |  |  |
| Depreciation and amortization | 14,549 | 15,445 | 28,833 | 31,030 |
| Interest expense | 20,880 | 32,969 | 46,552 | 66,669 |
| Interest income | (348) | (731) | (1,489) | (1,145) |
| Income taxes | 19,788 | 37,767 | 43,734 | 70,185 |
| **EBITDA** | 147,645 | 281,818 | 332,674 | 560,543 |
| Adjustments: |  |  |  |  |
| Pension and OPEB plan expenses (1) | 541 | 827 | 1,083 | 1,597 |
| Initial and follow-on public offering and related expenses (2) | — | 610 | 4 | 1,296 |
| Non-cash loss (gain) on foreign currency remeasurement (3) | 2,222 | 616 | (1,239) | 1,027 |
| Stock-based compensation (4) | 717 | 570 | 1,127 | 862 |
| Non-cash fixed asset write-off (5) | — | (37) | — | 2,894 |
| Related party Tax Receivable Agreement benefit(6) | — | — | (3,346) | — |
| **Adjusted EBITDA** | $151,125 | $284,404 | $330,303 | $568,219 |

(1) Service and interest cost of our OPEB plans. Also includes a mark-to-market loss (gain) for plan assets as of December of each year.

(2) Legal, accounting, printing and registration fees associated with the initial and follow-on public offering and related expenses.

(3) Non-cash gains and losses from foreign currency remeasurement of non-operating assets and liabilities of our non-U.S. subsidiaries where the functional currency is the U.S. dollar.

(4) Non-cash expense for stock-based compensation grants.

(5) Non-cash fixed asset write-off recorded for obsolete assets.

(6) Non-cash expense adjustment for future payment to our sole pre-IPO stockholder for tax assets that are expected to be utilized.

### Key Operating Metrics

In addition to measures of financial performance presented in accordance with GAAP, we use certain operating metrics to analyze the performance of our company. The key operating metrics consist of sales volume, production volume, production capacity and capacity utilization. These metrics align with management's assessment of our revenue performance and profit margin and will help investors understand the factors that drive our profitability.

Sales volume reflects only graphite electrodes manufactured by GrafTech. For a discussion of our revenue recognition policy, see our Annual Report on Form 10-K “Management’s Discussion and Analysis of Financial Condition and Results of Operations-Critical Accounting Policies-Revenue Recognition.” Sales volume helps investors understand the factors that drive our net sales.

Production volume reflects graphite electrodes produced during the period. Production capacity reflects expected maximum production volume during the period under normal operating conditions, standard product mix and expected maintenance downtime. Capacity utilization reflects production volume as a percentage of production capacity. Production volume, production capacity and capacity utilization help us understand the efficiency of our production, evaluate cost of sales and consider how to approach our contract initiative.

### Results of Operations

### The Three Months Ended June 30, 2020 Compared to the Three Months Ended June 30, 2019

The tables presented in our period-over-period comparisons summarize our Condensed Consolidated Statements of Operations and illustrate key financial indicators used to assess the consolidated financial results. Throughout our Management's Discussion and Analysis ("MD&A"), insignificant changes may be deemed not meaningful and are generally excluded from the discussion.

*(Dollars in thousands)*

|  | For the Three Months Ended June 30, 2020 | 2019 | Increase/ Decrease | % Change |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $280,718 | $480,390 | $(199,672) | (42)% |
| Cost of sales | 130,600 | 197,047 | (66,447) | (34)% |
| Gross profit | 150,118 | 283,343 | (133,225) | (47)% |
| Research and development | 710 | 713 | (3) | —% |
| Selling and administrative expenses | 16,001 | 15,394 | 607 | 4% |
| Operating income | 133,407 | 267,236 | (133,829) | (50)% |
| Other (income) expense, net | 311 | 863 | (552) | (64)% |
| Interest expense | 20,880 | 32,969 | (12,089) | (37)% |
| Interest income | (348) | (731) | 383 | (52)% |
| Income before provision for income taxes | 112,564 | 234,135 | (121,571) | (52)% |
| Provision for income taxes | 19,788 | 37,767 | (17,979) | (48)% |
| Net income | 92,776 | 196,368 | (103,592) | (53)% |

*Net sales.* Net sales decreased from $480.4 million in the three months ended June 30, 2019, to $280.7 million in the three months ended June 30, 2020. The decrease was primarily driven by a 31% decrease in sales volume of graphite electrodes reflecting lower steel production levels and the impact of the COVID-19 pandemic on the economy. Prices achieved from our long-term agreements were down approximately 4% in the three months ended June 30, 2020 compared to the same period of 2019, due primarily to mix. The spot price of graphite electrodes declined significantly in three months ended June 30, 2020 compared to the same period of 2019. We also had a reduction in the resale of purchased electrodes.

*Cost of sales.* We experienced a decrease in cost of sales from $197.0 million in the three months ended June 30, 2019, to $130.6 million in the three months ended June 30, 2020, primarily due to the lower sales volume of manufactured electrodes, which reduced cost of sales by $51.0 million as well as a reduction in resale of purchased electrodes. Additionally, cost of sales was lower due to less usage of third party needle coke.

*Selling and administrative expenses.* Selling and administrative expenses remained approximately flat from the three months ended June 30, 2020 as compared to the same period of 2019.

*Interest Expense*. Interest expense decreased from $33.0 million in the three months ended June 30, 2019, to $20.9 million in the three months ended June 30, 2020, primarily due to lower interest rates and lower average borrowings. During the three months ended June 30, 2020, we repaid $103.3 million of our term loans. We realized a $3.3 million benefit to interest expense resulting from gains on certain of these transactions in the three months ended June 30, 2020.

*Provision for income taxes.* The following table summarizes the expense for income taxes:

*(Dollars in thousands)*

|  | For the Three Months Ended September 30, 2020 | 2019 |
| --- | ---: | ---: |
| Tax expense | $19,788 | $37,767 |
| Pretax income | 112,564 | 234,135 |
| Effective tax rates | 17.6% | 16.1% |

The effective tax rate for the three months ended June 30, 2020 was 17.6%. This rate differs from the U.S. statutory rate of 21% primarily due to worldwide earnings from various countries taxed at different rates which is offset by the net increase related to the U.S. taxation of global intangible low taxed income ("GILTI") and the Section 250 Deduction and Foreign Tax Credits ("FTC").

The effective tax rate for the three months ended June 30, 2019 was 16.1%. This rate differs from the U.S. statutory rate of 21% primarily due to worldwide earnings from various countries taxed at different rates.

Tax expense decreased from $37.8 million for the three months ended June 30, 2019 to $19.8 million for the three months ended June 30, 2020. This change is primarily related to the reduction in profits.

### The Six Months Ended June 30, 2020 Compared to the Six Months Ended June 30, 2019

The tables presented in our period-over-period comparisons summarize our Condensed Consolidated Statements of Operations and illustrate key financial indicators used to assess the consolidated financial results. Throughout our MD&A, insignificant changes may be deemed not meaningful and are generally excluded from the discussion.

*(Dollars in thousands)*

|  | For the Six Months Ended June 30, 2020 | 2019 | Increase/ Decrease | % Change |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $599,364 | $955,384 | $(356,020) | (37)% |
| Cost of sales | 269,517 | 392,571 | (123,054) | (31)% |
| Gross profit | 329,847 | 562,813 | (232,966) | (41)% |
| Research and development | 1,422 | 1,350 | 72 | 5% |
| Selling and administrative expenses | 30,933 | 30,620 | 313 | 1% |
| Operating income | 297,492 | 530,843 | (233,351) | (44)% |
| Other (income) expense | (3,003) | 1,330 | (4,333) | (326)% |
| Related party Tax Receivable Agreement benefit | (3,346) | — | (3,346) | N/A |
| Interest expense | 46,552 | 66,669 | (20,117) | (30)% |
| Interest income | (1,489) | (1,145) | (344) | 30% |
| Income before provision for income taxes | 258,778 | 463,989 | (205,211) | (44)% |
| Provision for income taxes | 43,734 | 70,185 | (26,451) | (38)% |
| Net income | $215,044 | $393,804 | $(178,760) | (45)% |

*Net sales.* Net sales decreased by $356.0 million, or 37%, from $955.4 million in the six months ended June 30, 2019 to $599.4 million in the six months ended June 30, 2020. This decrease was driven by a 28% decrease in sales volume of manufactured electrodes in the six months ended June 30, 2020 compared to the same period in 2019, reflecting lower steel production levels and the impact of the COVID-19 pandemic on the economy. We also had a reduction in the resale of purchased electrodes.

*Cost of sales.* Cost of sales decreased by $123.1 million, or 31%, from $392.6 million in the six months ended June 30, 2019 to $269.5 million in the six months ended June 30, 2020. This decrease was primarily due to the lower sales volume of manufactured electrodes, which reduced costs of sales by $87.3 million, as well as a reduction in resale of purchased electrodes. Additionally, cost of sales was lower due to less usage of third party needle coke.

*Selling and administrative expenses.* Selling and administrative expenses were approximately flat for the six months ended June 30, 2020 compared to the six months ended June 30, 2019.

*Other (income) expense.* Other expense changed by $4.3 million, from expense of $1.3 million in the six months ended June 30, 2019 to income of $3.0 million in the six months ended June 30, 2020. This change was primarily due to advantageous non-cash foreign currency impacts on non-operating assets and liabilities.

*Related party Tax Receivable Agreement benefit.* During the first quarter of 2020, the Company recorded an adjustment to our Related-party payable-Tax Receivable Agreement liability resulting in a benefit of $3.3 million due to the revised profit expectation for the year 2020, primarily caused by the COVID-19 pandemic.

*Interest expense.* Interest expense decreased by $20.1 million from $66.7 million in the six months ended June 30, 2019 to $46.6 million in the same period of 2020, primarily due to lower interest rates and lower average borrowings. We made repayments of $125 million on our term loans in the first quarter of 2019 and $225 million in the fourth quarter of 2019. During the six months ended June 30, 2020, we repaid $103.3 million of our term loans. We realized a $3.3 million benefit to interest expense resulting from gains on certain of these transactions in the six months ended June 30, 2020.

*Provision for income taxes.* The following table summarizes the expense for income taxes:

*(Dollars in thousands)*

|  | For the Six Months Ended June 30, 2020 | 2019 |
| --- | ---: | ---: |
| Tax expense | $43,734 | $70,185 |
| Pre-tax income | 258,778 | 463,989 |
| Effective tax rates | 16.9% | 15.1% |

The effective tax rate for the six months ended June 30, 2020 was 16.9%. This rate differs from the U.S. statutory rate of 21% primarily due to worldwide earnings from various countries taxed at different rates, which was offset by a net increase related to the U.S. taxation of GILTI and FTC.

The tax expense decreased from $70.2 million for the six months ended June 30, 2019 to $43.7 million for the six months ended June 30, 2020 primarily from the decrease in earnings.

The effective tax rate for the six months ended June 30, 2019 was 15.1%. This rate differed from the U.S. statutory rate of 21% primarily due to worldwide earnings from various countries taxed at different rates.

GrafTech has considered the tax impact of COVID-19 legislation, including the U.S. Coronavirus Aid, Relief and Economic Security (CARES) Act and has concluded that there is no material tax impact in the second quarter of 2020. The Company continues to monitor the tax effects of any legislative changes.

### Effects of Changes in Currency Exchange Rates

When the currencies of non-U.S. countries in which we have a manufacturing facility decline (or increase) in value relative to the U.S. dollar, this has the effect of reducing (or increasing) the U.S. dollar equivalent cost of sales and other expenses with respect to those facilities. In certain countries in which we have manufacturing facilities, and in certain export markets, we sell in currencies other than the U.S. dollar. Accordingly, when these currencies increase (or decline) in value relative to the U.S. dollar, this has the effect of increasing (or reducing) net sales. The result of these effects is to increase (or decrease) operating profit and net income.

Many of the non-U.S. countries in which we have a manufacturing facility have been subject to significant economic and political changes, which have significantly impacted currency exchange rates. We cannot predict changes in currency exchange rates in the future or whether those changes will have net positive or negative impacts on our net sales, cost of sales or net income.

The impact of these changes in the average exchange rates of other currencies against the U.S. dollar on our net sales was a decrease of $0.3 million and $2.0 million for the three and six months ended June 30, 2020 compared to the same period of 2019. The impact of these changes on our cost of sales was a decrease of $1.2 million and $4.4 million for the three and six months ended June 30, 2020 compared to the same period of 2019.

We have in the past and may in the future use various financial instruments to manage certain exposures to risks caused by currency exchange rate changes, as described under “Part I, Item 3–Quantitative and Qualitative Disclosures about Market Risk.”

### Liquidity and Capital Resources

Our sources of funds have consisted principally of cash flow from operations and debt, including our credit facilities (subject to continued compliance with the financial covenants and representations). Our uses of those funds (other than for operations) have consisted principally of dividends, capital expenditures, scheduled debt repayments, optional debt repayments, share repurchases and other obligations. Disruptions in the U.S. and international financial markets could adversely affect our liquidity and the cost and availability of financing to us in the future.

We believe that we have adequate liquidity to meet our needs. As of June 30, 2020, we had liquidity of $434.6 million, consisting of $246.9 million of availability under our 2018 Revolving Facility (subject to continued compliance with the financial covenants and representations) and cash and cash equivalents of $187.7 million. We had long-term debt of $1,704.5 million and short-term debt of $8.1 million as of June 30, 2020. As of December 31, 2019, we had liquidity of $327.8 million consisting of $246.9 million available on our 2018 Revolving Facility (subject to continued compliance with the financial covenants and representations) and cash and cash equivalents of $80.9 million. We had long-term debt of $1,812.7 million and short-term debt of $0.1 million as of December 31, 2019.

As of June 30, 2020 and December 31, 2019, $95.1 million and $41.4 million, respectively, of our cash and cash equivalents were located outside of the United States. We repatriate funds from our foreign subsidiaries through dividends. All of our subsidiaries face the customary statutory limitation that distributed dividends do not exceed the amount of retained and current earnings. In addition, for our subsidiary in South Africa, the South Africa Central Bank requires that certain solvency and liquidity ratios remain above defined levels after the dividend distribution, which historically has not materially affected our ability to repatriate cash from this jurisdiction. The cash and cash equivalents balances in South Africa were $1.7 million and $0.8 million as of June 30, 2020 and December 31, 2019, respectively. Upon repatriation to the United States, the foreign source portion of dividends we receive from our foreign subsidiaries is no longer subject to U.S. federal income tax as a result of The Tax Cuts and Jobs Act (the "Tax Act").

***Cash flow and plans to manage liquidity.*** Our cash flow typically fluctuates significantly between quarters due to various factors. These factors include customer order patterns, fluctuations in working capital requirements, timing of tax payments, timing of capital expenditures, acquisitions, divestitures and other factors. Cash flow from operations is expected to remain at positive sustained levels due to the predictable earnings generated by our three-to-five-year sales contracts with our customers.

We had availability under the 2018 Revolving Facility of $246.9 million as of June 30, 2020 and December 31, 2019, which consisted of the $250 million limit reduced by $3.1 million of outstanding letters of credit.

On February 12, 2018, we entered into the 2018 Credit Agreement, which provides for the 2018 Revolving Facility and the 2018 Term Loan Facility. On February 12, 2018, our wholly owned subsidiary, GrafTech Finance, borrowed $1,500 million under the 2018 Term Loan Facility. The funds received were used to pay off our outstanding debt, including borrowings under our prior credit facility and the previously outstanding senior notes and accrued interest relating to those borrowings and the senior notes, declare and pay a dividend of $1,112 million to our sole pre-IPO stockholder, pay fees and expenses incurred in connection therewith and for other general corporate purposes.

On June 15, 2018, GrafTech entered into the First Amendment to its 2018 Credit Agreement. The First Amendment amends the 2018 Credit Agreement to provide for an additional $750 million in aggregate principal amount of the Incremental Term Loans to GrafTech Finance. The Incremental Term Loans increase the aggregate principal amount of term loans incurred by GrafTech Finance under the 2018 Credit Agreement from $1,500 million to $2,250 million. The Incremental Term Loans have the same terms as those applicable to the existing term loans under the 2018 Credit Agreement, including interest rate, payment and prepayment terms, representations and warranties and covenants. The Incremental Term Loans mature on February 12, 2025, the same date as the existing term loans. GrafTech paid an upfront fee of 1.00% of the aggregate principal amount of the Incremental Term Loans on the effective date of the First Amendment. The proceeds of the Incremental Term Loans were used to repay, in full, the $750 million of our existing debt to our sole pre-IPO stockholder.

On July 30, 2019, our Board of Directors authorized a program to repurchase up to $100 million of our outstanding common stock. We may purchase shares from time to time on the open market, including under Rule 10b5-1 and/or Rule 10b-18 plans. The amount and timing of repurchases are subject to a variety of factors including liquidity, stock price, applicable legal requirements, other business objectives and market conditions. We have repurchased 3,328,574 shares of common stock for a total purchase price of $30.1 million under this program since inception. There were no shares repurchased under this program during the three months ended June 30, 2020.

In April 2020, as a result of the deteriorating economic environment, our Board of Directors reduced our dividend rate to $0.01 per share or $0.04 on an annualized basis. We expect our Board of Directors to revisit the dividend level when economic conditions improve. There can be no assurance that we will pay dividends in the future in these amounts or at all. Our Board of Directors may change the timing and amount of any future dividend payments or eliminate the payment of future dividends in its sole discretion, without any prior notice to our stockholders. Our ability to pay dividends will depend upon many factors, including our financial position and liquidity, results of operations, legal requirements, restrictions that may be imposed by the terms of our current and future credit facilities and other debt obligations and other factors deemed relevant by our Board of Directors.

We repaid $125 million and $250 million on our 2018 Term Loan Facility in February and December 2019, respectively. During the second quarter of 2020, we repaid $103.3 million of our term loans. At the end of June 2020, we entered into several debt repurchase commitments totaling $8.0 million under our 2018 Term Loan Facility, which remained unsettled at the end of the month. These commitments settled in July 2020. In light of the recent economic downturn we are now prioritizing balance sheet flexibility and debt repayment. We anticipate using a majority of the remaining free cash flow that we generate in 2020 to repay debt but we will continue to examine opportunities to repurchase our common stock. As a result of government enacted COVID-19 relief in a foreign jurisdiction, we were able to defer a tax payment of $50.0 million that was scheduled to be made in the first quarter of 2020 until the fourth quarter of 2020. During the six months ended June 30, 2020, we paid $4.9 million to various tax collecting agencies worldwide.

Potential uses of our liquidity include dividends, share repurchases, capital expenditures, acquisitions, scheduled debt repayments, optional debt repayments and other general purposes. An improving economy, while resulting in improved results of operations, could increase our cash requirements to purchase inventories, make capital expenditures and fund payables and other obligations until increased accounts receivable are converted into cash. A downturn, including the current downturn caused by the COVID-19 pandemic, could significantly and negatively impact our results of operations and cash flows, which, coupled with increased borrowings, could negatively impact our credit ratings, our ability to comply with debt covenants, our ability to secure additional financing and the cost of such financing, if available.

In order to seek to minimize our credit risks, we may reduce our sales of, or refuse to sell (except for prepayment, cash on delivery or under letters of credit or parent guarantees), our products to some customers and potential customers. Our unrecovered trade receivables worldwide have not been material during the last two years individually or in the aggregate.

We manage our capital expenditures by taking into account quality, plant reliability, safety, environmental and regulatory requirements, prudent or essential maintenance requirements, global economic conditions, available capital resources, liquidity, long-term business strategy and return on invested capital for the relevant expenditures, cost of capital and return on invested capital of the Company as a whole and other factors.

Capital expenditures totaled $24.4 million in the six months ended June 30, 2020. We previously reduced our planned capital expenditures for the full year by approximately one-half to a level of $30-$35 million and we remain committed to this goal. We are managing inventory levels to match demand. Due to timing of purchases, inventory levels increased during the first quarter of 2020. We expect overall inventory levels to come down over the remainder of 2020.

In the event that operating cash flows fail to provide sufficient liquidity to meet our business needs, including capital expenditures, any such shortfall would need to be made up by increased borrowings under our 2018 Revolving Facility, to the extent available.

### Cash Flows

The following table summarizes our cash flow activities:

*(in millions)*

| Cash flow provided by (used in): | For the Six Months Ended June 30, 2020 | 2019 |
| --- | ---: | ---: |
| Operating activities | $287.7 | $359.0 |
| Investing activities | $(24.3) | $(29.1) |
| Financing activities | $(155.7) | $(174.4) |

#### Operating Activities

Cash flow from operating activities represents cash receipts and cash disbursements related to all of our activities other than investing and financing activities. Operating cash flow is derived by adjusting net income (loss) for:

- Non-cash items such as depreciation and amortization, impairment, post retirement obligations, and severance and pension plan changes;
- Gains and losses attributed to investing and financing activities such as gains and losses on the sale of assets and unrealized currency transaction gains and losses; and
- Changes in operating assets and liabilities, which reflect timing differences between the receipt and payment of cash associated with transactions and when they are recognized in results of operations.

The net impact of the changes in working capital (operating assets and liabilities), which are discussed in more detail below, include the impact of changes in: receivables, inventories, prepaid expenses, accounts payable, accrued liabilities, accrued taxes, interest payable and payments of other current liabilities.

During the six months ended June 30, 2020, changes in working capital resulted in a net source of funds of $34.1 million, which was impacted by:

- net cash inflows in accounts receivable of $58.7 million from the decrease in accounts receivable due to lower sales;
- net cash inflows of $6.1 million from the decrease in other current assets primarily due to value-added tax refunds received from foreign governments;
- net cash inflows from increased income taxes payable of $25.1 million resulting from our ability to defer a $50.0 million tax payment in a foreign jurisdiction resulting from government enacted COVID-19 relief, partially offset by lower required tax payments due to lower profitability; and
- net cash outflows from decreases in accounts payable and accruals of $52.9 million, due to lower purchases of third-party needle coke and payments made to our related-party for our tax receivable agreement.

Uses of cash in the six months ended June 30, 2020 included contributions to pension and other benefit plans of $1.8 million, cash paid for interest of $46.1 million and taxes paid of $4.9 million.

During the six months ended June 30, 2019, changes in working capital resulted in a net use of funds of $102.5 million, which was impacted by:

- net cash outflows in accounts receivable of $65.1 million from the increase in accounts receivable due to the timing of sales and collections, as shipments in the second quarter of 2019 were weighted towards the latter part of the quarter;
- net cash outflows from increases in inventory of $16.1 million, due primarily to higher priced raw materials;
- net cash inflows from the utilization of prepaid assets of $3.3 million;
- net cash outflows from decreased income taxes payable of $27.6 million, resulting from required tax payments as our profitability has increased; and
- net cash inflows from increases in accounts payable and accruals of $2.2 million, due to the timing of payments.

Uses of cash in the six months ended June 30, 2019 included contributions to pension and other benefit plans of $1.6 million, cash paid for interest of $62.8 million and taxes paid of $74.8 million.

#### Investing Activities

Net cash used in investing activities was $24.3 million during the six months ended June 30, 2020, resulting from capital expenditures.

Net cash used investing activities was $29.1 million during the six months ended June 30, 2019, resulting from capital expenditures.

#### Financing Activities

Net cash outflow from financing activities was $155.7 million during the six months ended June 30, 2020, which was the result of the repayment of $100.0 million on our Term Loans, $25.5 million of total dividends to stockholders and $30.1 million of stock repurchases.

Net cash outflow from financing activities was $174.4 million during the six months ended June 30, 2019, which was the result of our $125.0 million payment on our Term Loan debt and $49.4 million of total dividends to stockholders.

### Related Party Transactions

We have engaged in transactions with affiliates or related parties during 2020 and we expect to continue to do so in the future. These transactions include ongoing obligations under the Tax Receivable Agreement, Stockholders Rights Agreement and Registration Rights Agreement, each with Brookfield.

### Recent Accounting Pronouncements

We discuss recently adopted accounting standards in Note 1, "Organization and Summary of Significant Accounting Policies" of the Notes to Condensed Consolidated Financial Statements.

### Description of Our Financing Structure

We discuss our financing structure in more detail in Note 5, "Debt and Liquidity" of the Notes to Condensed Consolidated Financial Statements.

## Market risk

As filed, 4,923 characters.

We are exposed to market risks, primarily from changes in interest rates, currency exchange rates, energy commodity prices and commercial energy rates. From time to time, we enter into transactions that have been authorized according to documented policies and procedures in order to manage these risks. These transactions primarily relate to financial instruments described below. Since the counterparties to these financial instruments are large commercial banks and similar financial institutions, we do not believe that we are exposed to material counterparty credit risk. We do not use financial instruments for trading purposes.

Our exposure to changes in interest rates results primarily from floating rate long-term debt tied to LIBO Rate or Euro LIBO Rate.

Our exposure to changes in currency exchange rates results primarily from:

- sales made by our subsidiaries in currencies other than local currencies;
- raw material purchases made by our foreign subsidiaries in currencies other than local currencies; and
- investments in and intercompany loans to our foreign subsidiaries and our share of the earnings of those subsidiaries, to the extent denominated in currencies other than the U.S. dollar.

Our exposure to changes in energy commodity prices and commercial energy rates results primarily from the purchase or sale of refined oil products and the purchase of natural gas and electricity for use in our manufacturing operations.

*Interest rate risk management.* We periodically enter into agreements with financial institutions that are intended to limit our exposure to additional interest expense due to increases in variable interest rates. These instruments effectively cap our interest rate exposure. During the third quarter of 2019, we entered into interest rate swaps resulting in a net unrealized pre-tax loss of $14.1 million as of June 30, 2020 and net unrealized pre-tax gain of $2.9 million as of December 31, 2019.

*Currency rate management.* We enter into foreign currency derivatives from time to time to attempt to manage exposure to changes in currency exchange rates. These foreign currency derivatives, which include, but are not limited to, forward exchange contracts and purchased currency options, attempt to hedge global currency exposures. Forward exchange contracts are agreements to exchange different currencies at a specified future date and at a specified rate. Purchased currency options are instruments which give the holder the right, but not the obligation, to exchange different currencies at a specified rate at a specified date or over a range of specified dates. Forward exchange contracts and purchased currency options are carried at fair value.

The outstanding foreign currency derivatives represented no net gain or loss as of June 30, 2020 and a net pre-tax gain of $0.2 million as of December 31, 2019.

*Energy commodity management.* We have entered into commodity derivative contracts to effectively fix some or all of our exposure to refined oil products. The outstanding commodity derivative contracts represented a net unrealized pre-tax loss of $14.0 million and $3.7 million as of June 30, 2020 and December 31, 2019, respectively.

*Sensitivity analysis.* We use sensitivity analysis to quantify potential impacts that market rate changes may have on the underlying exposures as well as on the fair values of our derivatives. The sensitivity analysis for the derivatives represents the hypothetical changes in value of the hedge position and does not reflect the related gain or loss on the forecasted underlying transaction.

A hypothetical increase in interest rates of 100 basis points (1%) would have increased our interest expense by $3.2 million, net of the impact of our interest rate swap, for the six months ended June 30, 2020. The same 100 basis points increase would have resulted in an increase of $17.0 million in the fair value of our interest rate swap portfolio.

As of June 30, 2020, a 10% appreciation or depreciation in the value of the U.S. dollar against foreign currencies from the prevailing market rates would have resulted in a corresponding decrease of $3.6 million or a corresponding increase of $3.6 million, respectively, in the fair value of the foreign currency hedge portfolio.

A 10% increase or decrease in the value of the underlying commodity prices that we hedge would have resulted in a corresponding increase or decrease of $7.6 million in the fair value of the commodity hedge portfolio as of June 30, 2020. Because of the high correlation between the hedging instrument and the underlying exposure, fluctuations in the value of the instruments are generally offset by reciprocal changes in the value of the underlying exposure.

For further information related to the financial instruments described above, see Note 10 "Derivative Instruments" to the Notes to Condensed Consolidated Financial Statements.

## Controls and procedures

As filed, 1,691 characters.

*Evaluation of Disclosure Controls and Procedures.* Management is responsible for establishing and maintaining adequate disclosure controls and procedures at the reasonable assurance level. Disclosure controls and procedures are designed to ensure that information required to be disclosed by a reporting company in the reports that it files or submits under Section 13 or 15(d) of the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by it in the reports that it files under the Exchange Act is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2020. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that these controls and procedures were effective at the reasonable assurance level as of June 30, 2020.

*Changes in Internal Control over Financial Reporting*. There have been no changes in our internal control over financial reporting that occurred during the three months ended June 30, 2020 that materially affected or are reasonably likely to materially affect our internal control over financial reporting.

## Risk factors

As filed, 4,228 characters.

The following disclosure modifies the discussion of certain risks and uncertainties previously disclosed in Part I - Item 1A. of our Annual Report on Form 10-K. These risks and uncertainties, along with those previously disclosed, could materially adversely affect our business or financial results. Additional risks and uncertainties that are not presently known to us or that we deem immaterial may also impact our business or financial results.

***The COVID-19 pandemic has had, and is expected to continue to have, an adverse impact on our business, results of operations, financial position and cash flows.***

In December 2019, there was an outbreak of a novel strain of coronavirus ("COVID-19") identified in China that has since spread to nearly all regions of the world. The outbreak was subsequently declared a pandemic by the World Health Organization in March 2020. To date, the COVID-19 outbreak and preventative measures taken to contain or mitigate the outbreak have caused, and are continuing to cause, business slowdowns or shutdowns in affected areas and significant disruption in the financial markets and economy both globally and in the United States.

In response to the pandemic and related mitigation measures, we began implementing changes in our business in February 2020 to protect our employees and customers, and to support appropriate health and safety protocols, including: (i) canceling travel and eliminating in-person meetings, (ii) working from home where possible, and (iii) establishing a "Safe-Work Playbook" for our sites. Our plant procedures include temperature measurements where permitted, personal protective equipment, mandatory use of gloves, social distancing, frequent cleaning and disinfecting, and the use of daily check sheets to keep team members highly focused on these new procedures. As the pandemic continues, we continue to limit travel and have employees working from home where possible. While all of these measures have been necessary and appropriate, they have resulted in additional costs and have adversely impacted our business and financial performance.

While the outbreak has begun to subside in certain areas of the world where we operate and serve our customers, the infection rates in other areas continue to escalate. In areas that have shown improvement, there is still a continued risk of a surge in the spread of COVID-19 or a potential second wave effecting all areas. As a result, we are unable to predict the ultimate impact of the COVID-19 outbreak at this time. The pandemic has adversely affected, and is expected to continue to adversely affect, our business, results of operations, financial position and cash flows. Such effects may be material and the potential impacts include, but are not limited to:

- adverse impact on our customers, and resultant impact on demand for our products;
- disruptions at our facilities, including reductions in operating hours, labor shortages and changes in operating procedures, including for additional cleaning and disinfecting procedures;
- disruptions in our supply chain due to transportation delays, travel restrictions, raw material cost increases and shortages, and closures of businesses or facilities;
- reductions in our operating effectiveness due to workforce disruptions from COVID-19 restrictions and social distancing resulting from “shelter in place” and “stay at home” orders, and the unavailability of key personnel necessary to conduct our business activities; and
- volatility in the global financial markets, which could have a negative impact on our ability to access capital and additional sources of financing in the future.

In addition, we cannot predict the impact that COVID-19 will have on our customers, employees, suppliers and distributors, and any adverse impacts on these parties may have a material adverse impact on our business. The impact of COVID-19 may also exacerbate other risks discussed in Item 1A, “Risk Factors” section included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, any of which could have a material effect on us. This situation is changing rapidly and additional impacts may arise that we are not aware of currently.

Filed Aug 6, 2020.
Source: SEC EDGAR, the filing index for accession 0000931148-20-000107. Last ingested by Listed: Nov 10, 2026, 00:15 ET. No prices; not investment advice.
